Section 4: Clinical Pharmacy Services 2023
DOI: 10.1136/ejhpharm-2023-eahp.62
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-015 Role of clinical pharmacist in the optimisation of nirmatrelvir/ritonavir prescription in the emergency department

Abstract: Aim and Objectives To analyse the inflammatory marker platelet/lymphocyte ratio (PLR) as a predictor of efficacy in immunotherapy treatments; to assess whether there is a relationship between PLR value and response to treatment. Material and Methods Retrospective and observational study of patients diagnosed with NSCLC and treated with pembrolizumab in a tertiary hospital, from January 2018 to December 2021. We collected demographic variables (sex and age), ECOG, histology, presence of metastases, PD-L1 expres… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles